ASH 2014: Rough Notes from Dr. Clive Zent and ... - CLL Support

CLL Support

23,253 members39,949 posts

ASH 2014: Rough Notes from Dr. Clive Zent and Dr. Wiestner on Prognostic Factors and Resistance in CLL

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

Hi friends,

I have just posted on my blog: bkoffman.blogspot.com my rough notes from a lecture on CLL from ASH 2014. I hope it offers two things.

First it contains a flood of information on how our understanding of prognostic indicators, tumor heterogeneity, and clonal evolution is changing.

Second, it gives you a glance under the hood of what goes on at these meetings.

The CLL Society's website is coming very soon. Tons of new educational and supportive material and helpful links.

It has been a ton of work, and I so hope it helps meet some of the unmet needs of our community.

Stay strong

We are all in this together

Brian

bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

Thanks Brian. Yes it is rather like drinking from a fire hose! The comment from Dr. Clive Zent's presentation "Clonal Evolution: No longer believe we develop new clones but start with small one that grow." caught my eye. After all this time are you able to expand on what was meant by that?

Neil

bkoffman profile image
bkoffmanCLL CURE Hero in reply toAussieNeil

Very small, sometimes too small to find, sub clones probably grow at different rates, especially but not exclusively in response to therapy. Not everyone agrees, but it is looking more likely.

Not what you're looking for?

You may also like...

ASH 2014. Dr. Sharman discusses the biology of our CLL cells

Friends, This week on the CLL Society website http://cllsociety.org, we share the first part of an...
bkoffman profile image
CLL CURE Hero

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

It has been a while since I posted an interview on my blog first instead of the CLL Society...
bkoffman profile image
CLL CURE Hero

ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib

ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...
bkoffman profile image
CLL CURE Hero

CLL Society' s abstract on what we want in our disease management published today in the ASH CLL abstracts.

Hi, I am so excited. If you haven’t already, please check out our ASH abstract,....
bkoffman profile image
CLL CURE Hero

ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)

Friends In another interview from ASH 2013 that I just posted on my blog...
bkoffman profile image
CLL CURE Hero

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
Jm954 profile image
Jm954Administrator
AussieNeil profile image
AussieNeilAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.